DI DORSKY, CS CRUMPACKER - Annals of internal medicine, 1987 - Am Coll Physicians In the 5 years since its release for clinical use, acyclovir (9-[2-hydroxyethoxymethyl] guanine)
has proved to be a safe and effective agent for therapy of herpes simplex and varicella-zoster
infections. The drug's availability in topical, oral, and intravenous preparations has ... Cited by 101 - Related articles - All 3 versions
JC WADE, JD MEYERS - Annals of Internal Medicine, 1983 - Am Coll Physicians Six marrow transplant recipients receiving acyclovir at various dosages for herpesvirus infections
developed neurologic symptoms during treatment. Three were receiving concomitant human
alpha interferon, and all six had received previous intrathecal methotrexate. Symptoms ... Cited by 73 - Related articles - All 2 versions
EB Andrews, HH Tilson, BA Hurn, JF … - The American journal of …, 1988 - ncbi.nlm.nih.gov Observational epidemiologic methods are being used to evaluate the safety of acyclovir in
pregnancy. An essential component of this research is the establishment of a baseline expectation
of pregnancy outcomes among women with herpes not receiving acyclovir. Continuing ... Cited by 27 - Related articles
DM Spiegal, K Lau - JAMA, 1986 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Add to CiteULike Add to Connotea Add to ... Cited by 27 - Related articles - All 2 versions
CD Sibrack, LT Gutman, CM Wilfert, C McLaren, … - The Journal of Infectious …, 1982 - jstor.org Page 1. THE JOURNAL OF INFECTIOUS DISEASES * VOL. 146, NO. 5 * NOVEMBER
1982 C 1982 by The University of Chicago. All rights reserved. 0022-1899/82/4605-
0012$00.95 Pathogenicity of Acyclovir-Resistant Herpes ... Cited by 99 - Related articles - All 2 versions
B Bean, D Aeppli - The Journal of infectious diseases, 1985 - jstor.org Acyclovir, an important new antiviral agent, has recently been shown to be effective when given
iv for treatment of acute herpes zoster in normal [1, 2], as well as in im- munocompromised hosts
[3]. No adverse effects occurred when acyclovir was administered in a dose of 5 mg/kg ... Cited by 59 - Related articles - All 4 versions
PA Chatis, CH Miller, LE Schrager, CS … - New England Journal of …, 1989 - content.nejm.org Original Article from The New England Journal of Medicine -- Successful treatment
with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex
virus in a patient with acquired immunodeficiency syndrome.
Cited by 125 - Related articles - All 3 versions
OL Laskin - Archives of Internal Medicine, 1984 - archinte.highwire.org \s=b\Acyclovir is a selective antiherpes agent. Its selective activity Is by exploitation of differences
between the herpes\x=req-\ specific and host cell enzymes. The major route of elimination of
acyclovir Is via the kidney by glomerular filtration and renal tubular secretion. In ... Cited by 50 - Related articles - All 4 versions
DW Barry, SN Lehrman, MN Ellis - The Journal of antimicrobial …, 1986 - ncbi.nlm.nih.gov The emerging field of antiviral sensitivity testing must depend upon some of the lessons learned
from prior experience with anti-bacterial sensitivity testing, but also take into account additional
factors including intracellular drug distribution and metabolism as well as the unique ... Cited by 17 - Related articles
KS Erlich, J Mills, P Chatis, GJ Mertz, DF Busch, … - The New England journal …, 1989 - cat.inist.fr Acyclovir-resistant and herpes simplex virus infections in patients with the acquired
immunodeficiency syndrome. KS ERLICH, J MILLS, P CHATIS, GJ MERTZ, DF
BUSCH, SE FOLLANSBEE, RM GRANT, CS CRUMPACKER ... Cited by 309 - Related articles - All 4 versions
